drugset / Trial / NCT00404937

Tobradex BID Compared to TOBRADEX and TOBREX/Vehicle

NCT00404937

Phase 3 Withdrawn Alcon Research
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to compare the new formulation of Tobradex to the current approved formulation

Timeline

Start
2006-12
Primary completion
2006-12
Completion
2006-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Tobradex Unknown

Indications

No indication recorded.